Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Pneumococcal Infections D011008 7 associated lipids
Rheumatic Diseases D012216 7 associated lipids
Coronary Thrombosis D003328 7 associated lipids
Ear Diseases D004427 7 associated lipids
Pelvic Pain D017699 7 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Klebsiella Infections D007710 7 associated lipids
Glomerulonephritis, IGA D005922 7 associated lipids
Conjunctivitis D003231 7 associated lipids
Disseminated Intravascular Coagulation D004211 7 associated lipids
Behcet Syndrome D001528 7 associated lipids
Infant, Premature, Diseases D007235 7 associated lipids
Sneezing D012912 6 associated lipids
Thrombophilia D019851 6 associated lipids
Gliosis D005911 6 associated lipids
Heart Injuries D006335 6 associated lipids
Glomerulonephritis, Membranous D015433 6 associated lipids
Intestinal Obstruction D007415 6 associated lipids
Coronary Stenosis D023921 6 associated lipids
Xeroderma Pigmentosum D014983 6 associated lipids
Blood Loss, Surgical D016063 6 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Purpura, Thrombotic Thrombocytopenic D011697 6 associated lipids
Osteonecrosis D010020 5 associated lipids
Strongylida Infections D017206 5 associated lipids
Liver Failure D017093 5 associated lipids
Neoplastic Cells, Circulating D009360 5 associated lipids
Hepatitis, Alcoholic D006519 5 associated lipids
Granulomatosis with Polyangiitis D014890 5 associated lipids
Spasm D013035 5 associated lipids
Colonic Diseases D003108 5 associated lipids
Shock, Cardiogenic D012770 5 associated lipids
Hypertrophy, Right Ventricular D017380 4 associated lipids
Hepatitis B, Chronic D019694 4 associated lipids
Lymphoma, T-Cell, Cutaneous D016410 4 associated lipids
Milk Hypersensitivity D016269 4 associated lipids
Cholestasis, Intrahepatic D002780 4 associated lipids
Thrombasthenia D013915 4 associated lipids
Thrombocytosis D013922 4 associated lipids
Cluster Headache D003027 4 associated lipids
Optic Nerve Injuries D020221 4 associated lipids
Asphyxia Neonatorum D001238 4 associated lipids
Brain Injuries D001930 4 associated lipids
Hyperuricemia D033461 4 associated lipids
Bronchopulmonary Dysplasia D001997 4 associated lipids
Viremia D014766 4 associated lipids
Neoplasms, Germ Cell and Embryonal D009373 4 associated lipids
Burns, Inhalation D002059 4 associated lipids
AIDS Dementia Complex D015526 4 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Laidlaw TM and Boyce JA Platelets in patients with aspirin-exacerbated respiratory disease. 2015 J. Allergy Clin. Immunol. pmid:26051947
Zelanis A et al. Snake venom serine proteinases specificity mapping by proteomic identification of cleavage sites. 2015 J Proteomics pmid:25452133
Larkin EK et al. New risk factors for adult-onset incident asthma. A nested case-control study of host antioxidant defense. 2015 Am. J. Respir. Crit. Care Med. pmid:25408961
Kooijman S et al. Hematopoietic α7 nicotinic acetylcholine receptor deficiency increases inflammation and platelet activation status, but does not aggravate atherosclerosis. 2015 J. Thromb. Haemost. pmid:25345495
Jasamai M et al. Molecular docking study on platelet-activating factor antagonistic activity of bioactive compounds isolated from Guttiferae and Ardisia species. 2015 Nat. Prod. Res. pmid:25332053
Detopoulou P et al. The relation of diet with PAF and its metabolic enzymes in healthy volunteers. 2015 Eur J Nutr pmid:24639073
Morita K et al. [Pain relieving effect of platelet-activating factor (PAF) antagonists in a bone cancer pain model]. 2015 Nippon Yakurigaku Zasshi pmid:26256746
Plotkowski MC et al. Contribution of the platelet activating factor signaling pathway to cerebral microcirculatory dysfunction during experimental sepsis by ExoU producing Pseudomonas aeruginosa. 2015 Pathog Dis pmid:26187894
Sato A et al. Biotinylated heptapeptides substituted with a D-amino acid as platelet-activating factor inhibitors. 2015 Eur. J. Pharmacol. pmid:26142829
Sala-Cunill A and Cardona V Biomarkers of anaphylaxis, beyond tryptase. 2015 Curr Opin Allergy Clin Immunol pmid:26110683
Gao L et al. Steroid receptor coactivators 1 and 2 mediate fetal-to-maternal signaling that initiates parturition. 2015 J. Clin. Invest. pmid:26098214
Gill P et al. Platelets in the immune response: Revisiting platelet-activating factor in anaphylaxis. 2015 J. Allergy Clin. Immunol. pmid:26051949
Jiao D et al. Macrophages are the dominant effector cells responsible for IgG-mediated passive systemic anaphylaxis challenged by natural protein antigen in BALB/c and C57BL/6 mice. 2014 May-Jun Cell. Immunol. pmid:24751884
Flasiński M et al. Influence of platelet-activating factor, lyso-platelet-activating factor and edelfosine on Langmuir monolayers imitating plasma membranes of cell lines differing in susceptibility to anti-cancer treatment: the effect of plasmalogen level. 2014 J R Soc Interface pmid:24694892
Sato A et al. C-reactive protein specifically enhances platelet-activating factor-induced inflammatory activity in vivo. 2014 Eur. J. Pharmacol. pmid:25455842
Yu Y et al. Transactivation of epidermal growth factor receptor through platelet-activating factor/receptor in ovarian cancer cells. 2014 J. Exp. Clin. Cancer Res. pmid:25261977
Agrawal V et al. Platelet-activating factor: a role in preterm delivery and an essential interaction with Toll-like receptor signaling in mice. 2014 Biol. Reprod. pmid:25253732
Wang M et al. Mouse anaphylactic shock is caused by reduced cardiac output, but not by systemic vasodilatation or pulmonary vasoconstriction, via PAF and histamine. 2014 Life Sci. pmid:25252221
Liu X et al. Ginkgolide B inhibits platelet release by blocking Syk and p38 MAPK phosphorylation in thrombin-stimulated platelets. 2014 Thromb. Res. pmid:25223809
Kang LP et al. Steroidal saponins from Tribulus terrestris. 2014 Phytochemistry pmid:25172515
Wu KZ et al. Establishment of the method for screening the potential targets and effective components of huatuo reconstruction pill. 2014 Interdiscip Sci pmid:25172450
Nitoda E et al. Correlation of platelet activating factor and age-related macular degeneration. 2014 Expert Opin. Ther. Targets pmid:25077601
Sirangelo I et al. Platelet-activating factor mediates the cytotoxicity induced by W7FW14F apomyoglobin amyloid aggregates in neuroblastoma cells. 2014 J. Cell. Biochem. pmid:25053109
Xanthopoulou MN et al. Effect of Robola and Cabernet Sauvignon extracts on platelet activating factor enzymes activity on U937 cells. 2014 Food Chem pmid:25038648
Concha C et al. Oxidative response of neutrophils to platelet-activating factor is altered during acute ruminal acidosis induced by oligofructose in heifers. 2014 J. Vet. Sci. pmid:25013355
Mazereeuw G et al. Platelet-activating factors are associated with cognitive deficits in depressed coronary artery disease patients: a hypothesis-generating study. 2014 J Neuroinflammation pmid:24996486
Uhlig S et al. Differential regulation of lung endothelial permeability in vitro and in situ. 2014 Cell. Physiol. Biochem. pmid:24977477
Triggiani M et al. Anaphylaxis and cardiovascular diseases: a dangerous liaison. 2014 Curr Opin Allergy Clin Immunol pmid:24915548
Jin XL and O'Neill C Systematic analysis of the factors that adversely affect the rate of cell accumulation in mouse embryos during their culture in vitro. 2014 Reprod. Biol. Endocrinol. pmid:24885989
Papakonstantinou VD et al. In vivo effect of two first-line ART regimens on inflammatory mediators in male HIV patients. 2014 Lipids Health Dis pmid:24884881
Marathe GK et al. To hydrolyze or not to hydrolyze: the dilemma of platelet-activating factor acetylhydrolase. 2014 J. Lipid Res. pmid:24859738
Zanatta AL et al. Fish oil supplementation decreases oxidative stress but does not affect platelet-activating factor bioactivity in lungs of asthmatic rats. 2014 Lipids pmid:24858941
Mitchell MJ et al. Fluid shear stress increases neutrophil activation via platelet-activating factor. 2014 Biophys. J. pmid:24853753
Carlioglu A et al. The platelet activating factor acetyl hydrolase, oxidized low-density lipoprotein, paraoxonase 1 and arylesterase levels in treated and untreated patients with polycystic ovary syndrome. 2014 Arch. Gynecol. Obstet. pmid:24840107
Yu Y et al. Epidermal growth factor induces platelet-activating factor production through receptors transactivation and cytosolic phospholipase A2 in ovarian cancer cells. 2014 J Ovarian Res pmid:24721622
Forkel S et al. Inositoylated platelet-activating factor (Ino-C2-PAF) modulates dynamic lymphocyte-endothelial cell interactions and alleviates psoriasis-like skin inflammation in two complementary mouse models. 2014 J. Invest. Dermatol. pmid:24714204
Kim SJ et al. Quantitative determination of major platelet activating factors from human plasma. 2014 Anal Bioanal Chem pmid:24682147
Chacón-Salinas R et al. An essential role for platelet-activating factor in activating mast cell migration following ultraviolet irradiation. 2014 J. Leukoc. Biol. pmid:24009177
Mehta A and Sigman M Identification and preparation of sperm for ART. 2014 Urol. Clin. North Am. pmid:24286775
Reyes-Quiroz ME et al. Platelet-activating factor downregulates the expression of liver X receptor-α and its target genes in human neutrophils. 2014 FEBS J. pmid:24289152
Semini G et al. Inositol-C2-PAF down-regulates components of the antigen presentation machinery in a 2D-model of epidermal inflammation. 2014 Biochem. Pharmacol. pmid:24291779
Sugatani J et al. Antiobese function of platelet-activating factor: increased adiposity in platelet-activating factor receptor-deficient mice with age. 2014 FASEB J. pmid:24100020
Fang W et al. Platelet activating factor induces transient blood-brain barrier opening to facilitate edaravone penetration into the brain. 2014 J. Neurochem. pmid:24164378
Chérifi F et al. Isolation, functional characterization and proteomic identification of CC2-PLA₂ from Cerastes cerastes venom: a basic platelet-aggregation-inhibiting factor. 2014 Protein J. pmid:24384926
Gazos-Lopes F et al. Structural and functional analysis of a platelet-activating lysophosphatidylcholine of Trypanosoma cruzi. 2014 PLoS Negl Trop Dis pmid:25101628
Semini G et al. Glycosidated phospholipids - a promising group of anti-tumour lipids. 2014 Anticancer Agents Med Chem pmid:24628240
Morimoto R et al. Rapid production of platelet-activating factor is induced by protein kinase Cα-mediated phosphorylation of lysophosphatidylcholine acyltransferase 2 protein. 2014 J. Biol. Chem. pmid:24742674
Summers C et al. Pulmonary retention of primed neutrophils: a novel protective host response, which is impaired in the acute respiratory distress syndrome. 2014 Thorax pmid:24706039
Yang Y et al. Basophil activation through ASGM1 stimulation triggers PAF release and anaphylaxis-like shock in mice. 2014 Eur. J. Immunol. pmid:24777913
Tarui M et al. Selective inhibitors of a PAF biosynthetic enzyme lysophosphatidylcholine acyltransferase 2. 2014 J. Lipid Res. pmid:24850807